SUSAN CARR: Open Payments
NPI 1932414364 · HARRISVILLE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 44 payments from 19 companies in 2025. Trend: 2023 $117 · 2024 $34 · 2025 $815
Food & beverage: $799Education: $16
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $223 |
| GlaxoSmithKline, LLC. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| Janssen Biotech, Inc. | 3 | $60 |
| Incyte Corporation | 2 | $44 |
| Aveo Pharmaceuticals, Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Eisai Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Genmab U.S., Inc. | 1 | $29 |
Products named: ELIQUIS, ZEJULA, SCEMBLIX, FOTIVDA, DARZALEX, LIBTAYO, Lenvima, ELREXFIO.
Industry payments across WV — which companies pay providers there.
